These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 13292891)

  • 21. [The determination of contamination in the sterility testing by filtration of antimicrobial products].
    LAGODSKY H
    C R Seances Soc Biol Fil; 1960; 154():1435-7. PubMed ID: 13758236
    [No Abstract]   [Full Text] [Related]  

  • 22. New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?
    Giné CV; Espinosa IF; Vilamala MV
    Drug Test Anal; 2014; 6(7-8):819-24. PubMed ID: 24470121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspects of the purity control of drugs.
    Hoeke M
    Pharm Weekbl; 1971 Oct; 106(38):709-19. PubMed ID: 5159657
    [No Abstract]   [Full Text] [Related]  

  • 24. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. As production goes global, drug supply faces greater risks to safety, quality.
    Kuehn BM
    JAMA; 2011 Aug; 306(8):811-3. PubMed ID: 21862736
    [No Abstract]   [Full Text] [Related]  

  • 26. [Risks in the delivery of drugs from the point of manufacture to the patient. I. Risks in manufacturing and compounding].
    Samková M; Solich J
    Cesk Farm; 1981 Dec; 30(10):349-54. PubMed ID: 7332939
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of the chemical compatibility of plastic contact materials and pharmaceutical products; safety considerations related to extractables and leachables.
    Jenke D
    J Pharm Sci; 2007 Oct; 96(10):2566-81. PubMed ID: 17701994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirtieth report.
    World Health Organ Tech Rep Ser; 1987; 748():1-50. PubMed ID: 3111103
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of packaging in ethylene oxide sterilization.
    Panella JA
    Bull Parenter Drug Assoc; 1974; 28(4):188-96. PubMed ID: 4212326
    [No Abstract]   [Full Text] [Related]  

  • 30. Influence of compounding on sterility and stability of drugs.
    Hardee GE
    J Am Vet Med Assoc; 1994 Jul; 205(2):224-5. PubMed ID: 7928582
    [No Abstract]   [Full Text] [Related]  

  • 31. Strategies for the identification, control and determination of genotoxic impurities in drug substances: a pharmaceutical industry perspective.
    Raman NV; Prasad AV; Ratnakar Reddy K
    J Pharm Biomed Anal; 2011 Jun; 55(4):662-7. PubMed ID: 21193280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel single-labeled fluorescent oligonucleotide probe for silver(I) ion detection in water, drugs, and food.
    Bian L; Ji X; Hu W
    J Agric Food Chem; 2014 May; 62(21):4870-7. PubMed ID: 24784801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of trace melamine in raw materials used for protein pharmaceutical manufacturing using surface-enhanced Raman spectroscopy (SERS) with gold nanoparticles.
    Wen ZQ; Li G; Ren D
    Appl Spectrosc; 2011 May; 65(5):514-21. PubMed ID: 21513594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inorganic particle content of foods and drugs.
    Eisenberg WV
    Environ Health Perspect; 1974 Dec; 9():183-91. PubMed ID: 4377870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Microbiological requirements for non-compulsory sterile drugs].
    Aureli P; Pasolini B
    Boll Chim Farm; 1985 Jun; 124(6):229-43. PubMed ID: 4063090
    [No Abstract]   [Full Text] [Related]  

  • 36. Administrative detention of drugs intended for human or animal use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2014 May; 79(103):30716-21. PubMed ID: 24873018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Letter: Addition of drugs to intravenous fluids.
    Lancet; 1976 Apr; 1(7964):858. PubMed ID: 56671
    [No Abstract]   [Full Text] [Related]  

  • 38. [The microbiological faultlessness of drugs. III. Development and problems of testing methods].
    Sagáth J; Chalabala M; Bábik I
    Cesk Farm; 1978 Oct; 27(8):353-8. PubMed ID: 743754
    [No Abstract]   [Full Text] [Related]  

  • 39. [Practical methods for the determination of moisture in basic materials and in drugs].
    Rocchi B
    Boll Chim Farm; 1968 Mar; 107(3):143-57. PubMed ID: 5730322
    [No Abstract]   [Full Text] [Related]  

  • 40. Detection of low-level PTFE contamination: An application of solid-state NMR to structure elucidation in the pharmaceutical industry.
    Pham TN; Day CJ; Edwards AJ; Wood HR; Lynch IR; Watson SA; Bretonnet AS; Vogt FG
    J Pharm Biomed Anal; 2011 Jan; 54(2):401-5. PubMed ID: 20880648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.